![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C12N 5/00 | (2006.01) |
C12N 5/071 | (2010.01) | ||
C12N 15/67 | (2006.01) | ||
C12N 15/87 | (2006.01) | ||
C12N 15/85 | (2006.01) |
(11) | Number of the document | 3536776 |
(13) | Kind of document | T |
(96) | European patent application number | 19161388.4 |
Date of filing the European patent application | 2015-04-29 | |
(97) | Date of publication of the European application | 2019-09-11 |
(45) | Date of publication and mention of the grant of the patent | 2023-10-25 |
(46) | Date of publication of the claims translation | 2024-01-25 |
(30) | Number | Date | Country code |
201461985589 P | 2014-04-29 | US | |
201461994310 P | 2014-05-16 | US |
(72) |
LAUX, Holger , CH
ROMAND, Sandrine , CH
BODENDORF, Ursula , CH
|
(73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
(74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Naujos stuburinių ląstelės ir metodai, skirti rekombinantinei dominančio polipeptido raiškai |
NOVEL VERTEBRATE CELLS AND METHODS FOR RECOMBINANTLY EXPRESSING A POLYPEPTIDE OF INTEREST |
Payment date | Validity (years) | Amount | |
2025-03-21 | 11 | 289.00 EUR |
2026-04-29 |